The FDA granted 510(k) clearance for HyHub and HyHub Duo devices on July 21, 2025. Kristina Allikmets is senior vice president for Takeda.
1 report, 1 independent
Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA granted 510(k) clearance for HyHub and HyHub Duo devices on July 21, 2025. Kristina Allikmets is senior vice president for Takeda.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Takeda Pharmaceutical Company
Japanese pharmaceutical company
Nothing else this week.
Related events
- FDA granted 510(k) clearance for combined technologies for Solventum.
- The FDA granted 510(k) clearance to SimBioSys's software.
- Providence Medical Technology, Inc. received 510(k) clearance from the FDA and plans to showcase its system at the Henry B. González Convention Center.
- A company is seeking FDA 510(k) clearance while simultaneously conducting a private placement and qualifying its prospectus in British Columbia.
- Vivos is advancing its product line by securing patents via USPTO filings and gaining unprecedented 510K clearances for an alternative to CPAP technology.
Coverage
Newest first; wire copies grouped- Business WireTakeda Receives FDA 510(k) Clearance for HyHubTM and HyHubTM Duo Devices to Simplify HYQVIA® Administration HyHub and HyHub Duo Reduce the Number of Steps Required to Prepare HYQVIA1 First Devices Cu